Table 1 Patient characteristics
From: Risks of postoperative paresis in motor eloquently and non-eloquently located brain metastases
| Â | Â | Eloquent | Non-eloquent |
|---|---|---|---|
Number of patients | Â | 56 | 150 |
Preoperative paresis | Â | 57.0% | 47.3% |
Sex | Male | 32 (57.0%) | 72 (48.0%) |
Female | 24 (43.0%) | 78 (52.0%) | |
Median age ± SD |  | 61.4 ± 13.1 years | 60.9 ± 11.9 years |
Location | Precentral | 32.0% | - |
Frontal | 27.0% | 30.0% | |
Subcortical | 22.0% | - | |
Postcentral | 14.0% | - | |
Cerebellar | - | 20.0% | |
Occipital | - | 15.3% | |
Temporomesial | - | 13.3% | |
Parietal w/o postcentral gyrus | - | 9.3% | |
Other | - | 12.1% | |
Primary tumor | NSCLC | 30.4% | 29.5% |
Breast | 21.4% | 20.1% | |
Melanoma | 8.9% | 10.7% | |
Colon | 7.1% | 8.7% | |
RCC | 7.1% | 10.1% | |
CUP | 7.1% | 4.0% | |
Ovarian | 5.4% | 2.7% | |
Esophageal | 3.6% | 4.7% | |
Seminoma | 1.8% | 0.7% | |
Paranasial sinus | 1.8% | 0.7% | |
Urothelial | 1.8% | 0.7% | |
SCLC | 1.8% | 2.0% | |
Uterine sarcoma | 1.8% | 0.7% | |
Gastric | - | 1.3% | |
Larynx | - | 1.3% | |
Gall bladder | - | 0.7% | |
Parotid gland | - | 0.7% | |
Prostate | - | 0.7% | |
Number of brain metastases | 1 | 57.0% | 56.7% |
2 | 18.0% | 18.0% | |
3 | 11.0% | 10.3% | |
>3 | 14.0% | 15.0% | |
RPA score | 1 | 14.0% | 15.0% |
2 | 64.0% | 65.0% | |
3 | 22.0% | 20.0% | |
Preoperative therapy | Rtx | 5.4% | 2.7% |
(n = 150) | Ctx | 30.4% | 34.0% |
Rtx + Ctx | 14.3% | 19.3% |